These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 19170169)

  • 1. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
    Pu RT; Pang Y; Michael CW
    Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
    Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
    Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.
    Camilo R; Capelozzi VL; Siqueira SA; Del Carlo Bernardi F
    Hum Pathol; 2006 May; 37(5):542-6. PubMed ID: 16647951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: utility of an immunohistochemical panel containing CK5/6, CK34βE12, p63, CK7 and TTF-1.
    Xu XY; Yang GY; Yang JH; Li J
    Pathol Res Pract; 2014 Oct; 210(10):680-5. PubMed ID: 25063315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
    Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
    Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.